Sue Gail Eckhardt insider trades

Open-market stock purchases and sales by Sue Gail Eckhardt, Director at Exelixis, Inc, from SEC Form 4 filings since Sep 8, 2020.

Recent trades

DateStockTradeValue
Jun 1, 2026EXEL Exelixis, IncSold$492K
May 27, 2026EXEL Exelixis, IncBought (not open market)—
Feb 13, 2026EXEL Exelixis, IncSold$169K

Companies traded

  • EXEL Exelixis, Inc: 6 sales, last Jun 1, 2026
  • SYRS Syros Pharmaceuticals, Inc: other filings, last Jun 5, 2024

Get free alerts when Sue Gail Eckhardt files a new trade →